组别 | 例数 | Scr (μmol/L) | TNF-α (ng/L) | IL-1 (ng/L) | IL-8 (ng/L) | ||||
治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | ||
对照组 | 82 | 511.25 ± 60.62 | 113.62 ± 14.26 | 216.65 ± 18.24 | 124.62 ± 10.25 | 212.35 ± 9.54 | 133.16 ± 9.82 | 1761.42 ± 112.35 | 844.82 ± 48.76 |
观察组 | 102 | 510.32 ± 58.74 | 154.56 ± 18.94 | 217.25 ± 19.42 | 150.32 ± 12.37 | 211.94 ± 9.82 | 148.46 ± 8.46 | 1758.23 ± 108.46 | 967.46 ± 42.33 |
t | - | 0.10 | 8.29 | 0.21 | 15.10 | 0.28 | 11.34 | 0.19 | 18.25 |
P | - | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 |